Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Somaliland denies trading recognition with Israel for accepting Gazans - 2Zelensky sees win for Ukraine as EU finally reaches funding deal
- 3I traveled to 13 countries in 2025. This small island nation surprised me the most.
- 4Drones, physics and rats: Studies show how the people of Rapa Nui made and moved the giant statues – and what caused the island’s deforestation
- 5'We are ready': NASA still on track to launch Artemis 2 astronauts to the moon April 1
- Italy fertility rate fell to new low of 1.14 in 2025
- Tuesday, April 7. Russia’s War On Ukraine: News And Information From Ukraine
- Vote in favor of Your #1 4\u00d74 SUVs
- The 2026 'Super Bowl of Astronomy' starts today — here's what's happening
- Which Breakfast Enraptures Your Taste Buds? Vote
- Scientists reveal earliest evidence for shifting of Earth’s crust
- The Best 20 Photography Instagram Records to Follow
- Family Holiday spots
- Check out the exclusive pitch deck Valerie Health used to raise $30 million from Redpoint Ventures to automate healthcare faxes
